1,25(OH)2VD3 actively induced bone marrow stroma to release CXCL12 in vitro, and increased CXCL12 serum levels in vivo, resulting in an increased ability to attract the BCR-ABL+ Arf−/− ALL to the marrow and support its growth. Here, ABL1 is linked to acute lymphoblastic leukemia.